Literature DB >> 19564866

A case for immunosuppression for myoblast transplantation in duchenne muscular dystrophy.

Jacques P Tremblay1, Daniel Skuk, Benjamino Palmieri, David M Rothstein.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19564866      PMCID: PMC2835209          DOI: 10.1038/mt.2009.125

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  23 in total

1.  Myoblast transplantation in whole muscle of nonhuman primates.

Authors:  D Skuk; M Goulet; B Roy; J P Tremblay
Journal:  J Neuropathol Exp Neurol       Date:  2000-03       Impact factor: 3.685

2.  Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation.

Authors:  E Gussoni; G K Pavlath; A M Lanctot; K R Sharma; R G Miller; L Steinman; H M Blau
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

3.  Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy.

Authors:  J P Tremblay; J P Bouchard; F Malouin; D Théau; F Cottrell; H Collin; A Rouche; S Gilgenkrantz; N Abbadi; M Tremblay
Journal:  Neuromuscul Disord       Date:  1993 Sep-Nov       Impact factor: 4.296

4.  Lymphomas after solid organ transplantation: a collaborative transplant study report.

Authors:  Gerhard Opelz; Bernd Döhler
Journal:  Am J Transplant       Date:  2004-02       Impact factor: 8.086

5.  Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy.

Authors:  J P Tremblay; F Malouin; R Roy; J Huard; J P Bouchard; A Satoh; C L Richards
Journal:  Cell Transplant       Date:  1993 Mar-Apr       Impact factor: 4.064

6.  Use of mononuclear precursor cells to insert allogeneic genes into growing mouse muscles.

Authors:  D J Watt; J E Morgan; T A Partridge
Journal:  Muscle Nerve       Date:  1984 Nov-Dec       Impact factor: 3.217

7.  Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts.

Authors:  T A Partridge; J E Morgan; G R Coulton; E P Hoffman; L M Kunkel
Journal:  Nature       Date:  1989-01-12       Impact factor: 49.962

8.  Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study.

Authors:  Vikas R Dharnidharka; Ping-Leung Ho; Donald M Stablein; William E Harmon; Amir H Tejani
Journal:  Pediatr Transplant       Date:  2002-10

9.  Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells.

Authors:  Daniel Skuk; Brigitte Roy; Marlyne Goulet; Pierre Chapdelaine; Jean-Pierre Bouchard; Raynald Roy; Francine J Dugré; Jean-Guy Lachance; Louise Deschênes; Senay Hélène; Michel Sylvain; Jacques P Tremblay
Journal:  Mol Ther       Date:  2004-03       Impact factor: 11.454

10.  Very efficient myoblast allotransplantation in mice under FK506 immunosuppression.

Authors:  I Kinoshita; J T Vilquin; B Guérette; I Asselin; R Roy; J P Tremblay
Journal:  Muscle Nerve       Date:  1994-12       Impact factor: 3.217

View more
  4 in total

1.  The skeletal muscle satellite cell: still young and fascinating at 50.

Authors:  Zipora Yablonka-Reuveni
Journal:  J Histochem Cytochem       Date:  2011-12       Impact factor: 2.479

Review 2.  Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies.

Authors:  Sridhar Selvaraj; Michael Kyba; Rita C R Perlingeiro
Journal:  Trends Mol Med       Date:  2019-09       Impact factor: 11.951

Review 3.  Restoring dystrophin expression in duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through.

Authors:  Eric P Hoffman; Abby Bronson; Arthur A Levin; Shin'ichi Takeda; Toshifumi Yokota; Andreas R Baudy; Edward M Connor
Journal:  Am J Pathol       Date:  2011-05-23       Impact factor: 4.307

Review 4.  Potential Therapies Using Myogenic Stem Cells Combined with Bio-Engineering Approaches for Treatment of Muscular Dystrophies.

Authors:  Norio Motohashi; Yuko Shimizu-Motohashi; Thomas C Roberts; Yoshitsugu Aoki
Journal:  Cells       Date:  2019-09-11       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.